About: Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2001 (uk) im September 2001 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 2001 (ast) scientific article published on 01 September 2001 (en)
publication date	wds:Q74502702-6BD2E15E-35A8-4E8D-975F-89DD19FE2C15
publication date	2001-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74502702-44BC2D4C-53B1-4472-94F8-9B371B8A5407
language of work or name	English
author name string	wds:Q74502702-15C73606-6B6E-44A6-A0E0-7FF006CCECE6 wds:Q74502702-24EF8390-C1BB-4D55-95C0-FE5957DE484A wds:Q74502702-6765B4C3-FD28-4E4E-AA4F-93B0D6B1ECCA wds:Q74502702-691B679D-9B5F-4CCA-A34D-0CD3846A17ED wds:Q74502702-79EAF62A-1BB1-4F63-B335-27A3EEEEE1D5 wds:Q74502702-81791EF6-E2C6-4253-97DF-55FEF6247F84 wds:Q74502702-9A1E7E5B-77BC-4D15-A1D1-4F54BD808D05 wds:Q74502702-A370AA44-5887-4B88-96D5-F8357E4D0497 wds:Q74502702-B50A1491-D818-4190-9CC7-EDBCE7BB48F6 wds:Q74502702-BCF14933-7076-41A8-864A-72ACB9D568E1
author name string	C Morris A Fassas B Barlogie G Tricot M Zangari E Siegel N Munshi E Anaissie R Desikan A Badros
rdfs:label	Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years (en) Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years (nl)
skos:prefLabel	Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years (en) Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years (nl)
name	Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years (en) Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years (nl)
title	wds:Q74502702-2C894D27-7210-4594-B77E-1DBDA0A8F634
title	Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years (en)
page(s)	wds:Q74502702-0B51C2E6-F491-4E15-839E-E8E8D1BA3FA4
page(s)	600-607
instance of	wds:Q74502702-06FCDBC8-4205-4B5A-9ABD-E46BAF56FBD3
instance of	scholarly article
main subject	wds:Q74502702-2C173EE8-F8A1-473E-A44A-B3576251707D wds:Q74502702-791E1596-79F1-4C1D-A9A7-75CB497600C9
main subject	multiple myeloma stem cell transplantation
PubMed ID	wds:Q74502702-95E54F05-45CA-43EE-8304-3ED0612281BD
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11552985
PubMed ID	11552985
published in	wds:Q74502702-89A33ED3-595E-4286-8214-622FA1F69A48
published in	British Journal of Haematology
issue	wds:Q74502702-F96FFE43-5A98-4785-8097-2F0237EB18F7
volume	wds:Q74502702-E7C603AB-FBE3-41B6-A3A1-9D0A2AE911B6
issue	3
volume	114
DOI	wds:Q74502702-282745E4-CDB9-4065-A2BE-D02DA99D7FF6
DOI	http://dx.doi.org/10.1046/J.1365-2141.2001.02976.X
DOI	10.1046/J.1365-2141.2001.02976.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74502702
is cites work of	Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma. Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers Older patients with myeloma derive similar benefit from autologous transplantation. Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients. Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age. Autologous stem cell transplantation beyond 60 years of age. High-dose chemotherapy and auto-SCT in elderly patients with Hodgkin's lymphoma. Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma. High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (>or=65 years) myeloma patients: comparison with younger patients treated on the same protocol Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115. The role of stem cell transplantation in multiple myeloma Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myeloma Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65. Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate Is there an upper age limit for bone marrow transplantation? Age has no influence on mobilization of peripheral blood stem cells in acute myeloid leukemia. How we manage autologous stem cell transplantation for patients with multiple myeloma Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis Fifty years of melphalan use in hematopoietic stem cell transplantation High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation Multiple myeloma High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years The Diagnosis and Treatment of Multiple Myeloma Autologous stem cell transplantation in the elderly including pre- and post-treatment options Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions? Melphalan 140mg/m2 or 200mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party. Hematopoietic Cell Transplant (HCT) in the Elderly: Myths, Controversies and Unknowns The evolution of stem-cell transplantation in multiple myeloma. Current status of autologous stem cell transplantation for multiple myeloma DNA-binding agents Patient eligibility for hematopoietic stem cell transplantation: a review of patient-associated variables

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software